Khumpirapang Nattakanwadee, Suknuntha Krit, Wongrattanakamon Pathomwat, Jiranusornkul Supat, Anuchapreeda Songyot, Wellendorph Petrine, Müllertz Anette, Rades Thomas, Okonogi Siriporn
Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand.
Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla 90112, Thailand.
Pharmaceutics. 2022 Mar 16;14(3):650. doi: 10.3390/pharmaceutics14030650.
The anesthetic effect of oil (AGO) has been reported. However, knowledge of its pathway in mammals is limited. In the present study, the binding of AGO and its key compounds, methyl eugenol, 1,8-cineole, and 4-allylphenyl acetate, to gamma-aminobutyric acid type A (GABA) receptors in rat cortical membranes, was investigated using a [H]muscimol binding assay and an in silico modeling platform. The results showed that only AGO and methyl eugenol displayed a positive modulation at the highest concentrations, whereas 1,8-cineole and 4-allylphenyl acetate were inactive. The result of AGO correlated well to the amount of methyl eugenol in AGO. Computational docking and dynamics simulations into the GABA receptor complex model (PDB: 6X3T) showed the stable structure of the GABA receptor-methyl eugenol complex with the lowest binding energy of -22.16 kcal/mol. This result shows that the anesthetic activity of AGO and methyl eugenol in mammals is associated with GABA receptor modulation. An oil-in-water nanoemulsion containing 20% w/w AGO (NE-AGO) was formulated. NE-AGO showed a significant increase in specific [H]muscimol binding, to 179% of the control, with an EC of 391 µg/mL. Intracellular studies show that normal human cells are highly tolerant to AGO and the nanoemulsion, indicating that NE-AGO may be useful for human anesthesia.
已报道了茴芹籽油(AGO)的麻醉作用。然而,其在哺乳动物体内的作用途径尚不清楚。在本研究中,使用[H]蝇蕈醇结合试验和计算机模拟平台,研究了AGO及其关键化合物甲基丁香酚、1,8-桉叶素和乙酸4-烯丙基苯酯与大鼠皮层膜中γ-氨基丁酸A型(GABA)受体的结合情况。结果表明,只有AGO和甲基丁香酚在最高浓度时表现出正向调节作用,而1,8-桉叶素和乙酸4-烯丙基苯酯无活性。AGO的结果与AGO中甲基丁香酚的含量密切相关。对GABA受体复合物模型(PDB:6X3T)进行的计算对接和动力学模拟显示,GABA受体-甲基丁香酚复合物结构稳定,最低结合能为-22.16 kcal/mol。该结果表明,AGO和甲基丁香酚在哺乳动物中的麻醉活性与GABA受体调节有关。制备了一种含20%w/w AGO的水包油纳米乳剂(NE-AGO)。NE-AGO使特异性[H]蝇蕈醇结合显著增加,达到对照的179%,EC为391 µg/mL。细胞内研究表明,正常人细胞对AGO和纳米乳剂具有高度耐受性,这表明NE-AGO可能对人类麻醉有用。